Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

Stopped early

Conditions studied: Brain Tumor

In brief

The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.

Key facts

Study ID

NCT00775320

Run by

University of Oklahoma

People needed

13

Starts

2008-10-01

Expected to finish

2010-08-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Women must not be pregnant or breast feeding
• Histologic or strong radiologic suspicion of high grade malignant glioma or ogliometastatic tumor(s)

You may not qualify if…

• May not have received previous therapy for their malignancy

Where it is running

• University Of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.